Low grade intravascular hemolysis associates with peripheral nerve injury in type 2 diabetes

Type 2 diabetes (T2D) induces hyperglycemia, alters hemoglobin (Hb), red blood cell (RBC) deformability and impairs hemorheology. The question remains whether RBC breakdown and intravascular hemolysis (IVH) occur in T2D patients. We characterized RBC-degradation products and vesiculation in a case-control study of 109 T2D patients and 65 control subjects. We quantified heme-related absorbance by spectrophotometry and circulating extracellular vesicles (EV) by flow cytometry and electron microscopy. Heme-related absorbance was increased in T2D vs. control plasma (+57%) and further elevated in obese T2D plasma (+27%). However, large CD235a+ EV were not increased in T2D plasma. EV from T2D plasma, or shed by isolated T2D RBC, were notably smaller in diameter (-27%) and carried heme-related absorbance. In T2D plasma, higher heme-related absorbance (+30%) was associated to peripheral sensory neuropathy, and no other vascular complication. In vitro, T2D RBC-derived EV triggered endothelial stress and thrombin activation in a phosphatidylserine- and heme-dependent fashion. We concluded that T2D was associated with low-grade IVH. Plasma absorbance may constitute a novel biomarker of peripheral neuropathy in T2D, while flow cytometry focusing on large EV may be maladapted to characterize RBC EV in T2D. Moreover, therapeutics limiting IVH or neutralizing RBC breakdown products might bolster vasculoprotection in T2D.

[1]  E. Bourdon,et al.  Erythrocytes: Central Actors in Multiple Scenes of Atherosclerosis , 2021, International journal of molecular sciences.

[2]  E. Bourdon,et al.  Enhanced oxidative stress and damage in glycated erythrocytes , 2020, PloS one.

[3]  J. Pernow,et al.  Red Blood Cell Peroxynitrite Causes Endothelial Dysfunction in Type 2 Diabetes Mellitus via Arginase , 2020, Cells.

[4]  M. Bozza,et al.  Pro-inflammatory Actions of Heme and Other Hemoglobin-Derived DAMPs , 2020, Frontiers in Immunology.

[5]  A. Zonderman,et al.  Extracellular vesicles in diabetes mellitus induce alterations in endothelial cell morphology and migration , 2020, Journal of Translational Medicine.

[6]  10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020 , 2019, Diabetes Care.

[7]  G. Hindricks,et al.  2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. , 2019, Atherosclerosis.

[8]  J. Pernow,et al.  Red blood cell dysfunction: a new player in cardiovascular disease. , 2019, Cardiovascular research.

[9]  M. Mohty,et al.  Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients , 2019, Critical Care.

[10]  P. Anyfanti,et al.  Increased erythrocyte- and platelet-derived microvesicles in newly diagnosed type 2 diabetes mellitus , 2019, Diabetes & vascular disease research.

[11]  V. Novakovic,et al.  Phosphatidylserine on microparticles and associated cells contributes to the hypercoagulable state in diabetic kidney disease , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[13]  C. Östenson,et al.  Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I. , 2018, Journal of the American College of Cardiology.

[14]  S. Miescher,et al.  Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles. , 2018, JCI insight.

[15]  T. V. van Leeuwen,et al.  Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation , 2018, Journal of thrombosis and haemostasis : JTH.

[16]  Young Seol Kim,et al.  The Role of Advanced Glycation End Products in Diabetic Vascular Complications , 2018, Diabetes & metabolism journal.

[17]  M. Mattson,et al.  Altered Extracellular Vesicle Concentration, Cargo, and Function in Diabetes , 2018, Diabetes.

[18]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. , 2018, Diabetes research and clinical practice.

[19]  Ying Su,et al.  Procoagulant Activity of Blood and Endothelial Cells via Phosphatidylserine Exposure and Microparticle Delivery in Patients with Diabetic Retinopathy , 2018, Cellular Physiology and Biochemistry.

[20]  M. Ziol,et al.  Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[21]  Zhiyi Zuo,et al.  Haptoglobin 2‐2 Phenotype Is Associated With Increased Acute Kidney Injury After Elective Cardiac Surgery in Patients With Diabetes Mellitus , 2017, Journal of the American Heart Association.

[22]  C. Weber,et al.  Microvesicles in vascular homeostasis and diseases , 2017, Thrombosis and Haemostasis.

[23]  Fantao Meng,et al.  Determination of extinction coefficients of human hemoglobin in various redox states. , 2017, Analytical biochemistry.

[24]  R. Freeman,et al.  Diabetic Neuropathy: A Position Statement by the American Diabetes Association , 2016, Diabetes Care.

[25]  Tigist Kassa,et al.  Differential heme release from various hemoglobin redox states and the upregulation of cellular heme oxygenase‐1 , 2016, FEBS open bio.

[26]  G. Vilahur,et al.  Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients. , 2016, Revista espanola de cardiologia.

[27]  Thomas J. Smart,et al.  Assessment of red blood cell deformability in type 2 diabetes mellitus and diabetic retinopathy by dual optical tweezers stretching technique , 2016, Scientific Reports.

[28]  L. Kiger,et al.  Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. , 2015, Blood.

[29]  R. Thorne,et al.  The origin of circulating CD36 in type 2 diabetes , 2013, Nutrition & Diabetes.

[30]  M. Taskinen,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, Atherosclerosis.

[31]  L. Roberts,et al.  Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. , 2011, Free radical biology & medicine.

[32]  Janet S. Lee,et al.  Nitric Oxide Scavenging by Red Blood Cell Microparticles and Cell-Free Hemoglobin as a Mechanism for the Red Cell Storage Lesion , 2011, Circulation.

[33]  F. Hu,et al.  Plasma Heme Oxygenase-1 Concentration Is Elevated in Individuals with Type 2 Diabetes Mellitus , 2010, PloS one.

[34]  S. Kono,et al.  Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. , 2010, Diabetes research and clinical practice.

[35]  G. Leftheriotis,et al.  Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. , 2008, The American journal of pathology.

[36]  D. Owens,et al.  Anemia and diabetes in the absence of nephropathy. , 2005, Diabetes care.

[37]  M. Gladwin,et al.  The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. , 2005, JAMA.

[38]  M. Rondanelli,et al.  Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes Published, JLR Papers in Press, July 1, 2004. DOI 10.1194/jlr.M300509-JLR200 , 2004, Journal of Lipid Research.

[39]  Merlin C. Thomas,et al.  Unrecognized anemia in patients with diabetes: a cross-sectional survey. , 2003, Diabetes care.

[40]  R. Nieuwland,et al.  Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus , 2002, Circulation.

[41]  J. Louderback,et al.  Nitric oxide binding to oxygenated hemoglobin under physiological conditions. , 2001, Biochimica et biophysica acta.

[42]  W. Oyen,et al.  Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. , 2001, Blood.

[43]  A. Tappel,et al.  Oxidation of heme proteins as a measure of oxidative damage to liver tissue slices. , 1993, Free radical biology & medicine.

[44]  M. Laakso,et al.  Diabetes and atherosclerosis: an epidemiologic view. , 1987, Diabetes/metabolism reviews.

[45]  J. Chung,et al.  The duration of diabetes is inversely associated with the physiological serum bilirubin levels in patients with type 2 diabetes. , 2015, Internal medicine.

[46]  E. Oda,et al.  Bilirubin is negatively associated with hemoglobin a(1c) independently of other cardiovascular risk factors in apparently healthy Japanese men and women. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[47]  E. Friedman,et al.  Association of reduced red blood cell deformability and diabetic nephropathy. , 2005, Kidney international.

[48]  M. Gladwin,et al.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease , 2002, Nature Medicine.

[49]  D. Rein,et al.  Multicomponent analysis of heme protein spectra in biological materials. , 1996, Analytical biochemistry.